Synthesis of Some New Fused and Binary 1,3,4‐Thiadiazoles as Potential Antitumor and Antioxidant Agents

Annulations of 2‐amino‐1,3,4‐thiadiazole ( 1 ) with α,β‐unsaturated carbonyl compounds 2 , 5 , and 9 afforded thiadiazolo[3,2‐a]pyrimidin 3 , benzamide 7 , and bis‐pyrazole derivative 11 . Cyclization of benzamide 7 with POCl₃ gave binary imidazole derivative 8 . Moreover, alkylation of 1 with 2‐bromo‐1‐(2H‐chromen‐3‐yl) ethanone ( 9 ) followed by cyclization gave imidazo[2,1‐b]‐1,3,4‐thiadiazole derivative 15 . Multicomponent reaction of 1 with heterocyclic and/or aromatic aldehyde and thioglycolic acid afforded the corresponding thiazolidinones 17 and 19 . Finally, a one‐pot synthesis of 1 with isatin and thiosemicarbazide furnished the spirotriazole 20 . The newly synthesized compounds were evaluated as antitumor agents.     

1-Phenyl-2-thiocyanatoethanone as Synthons in Heterocyclic Synthesis

This review presents a systematic and comprehensive survey of the method of preparation and the chemical reactivity of 1-phenyl-2-thiocyanatoethanone. The target compound is an important intermediate for the synthesis of a variety of synthetically useful and novel heterocyclic systems.     

Enantiospecific Synthesis and Cytotoxicity Evaluation of Ligudentatol: A Programmed Aromatization Approach to the 2,3,4‐Trisubstituted Phenolic Motif via Visible‐Light‐Mediated Group Transfer Radical Cyclization

A facile enantiospecific approach to (+)‐ligudentatol ( 1 ) and (?)‐ligudentatol (ent‐ 1 ) is reported. The approach features the construction of a trisubstituted phenolic motif fused to a chiral aliphatic ring by a sequence of visible‐light‐mediated radical seleno transfer cyclization, bromination, concomitant selenoxide elimination–dehydrobromination, and demethoxycarbonylation, namely, a programmed aromatization. Biological evaluation of the enantiomers of ligudentatol obtained by the present route revealed for the first time their cytotoxicity towards various cancer cell lines.     

The fractional q-differential transformation and its application

In this paper, the definitions and operations of the one-dimensional and two-dimensional fractional q-differential transform is proposed. A distinctive feature of the fractional q-differential transform is its ability to solve linear and nonlinear ordinary/partial fractional q-differential equations.     

Synthesis of Some New Heterocycles of Pharmaceutical Interest: Pyridinyl and Isoxazolyl Quinoxaline Derivatives

3‐(p‐Acetyl‐anilinomethyl)quinoxalin‐2(1H)‐one ( 3 ) was prepared by the reaction of 3‐bromomethyl‐quinoxalin‐2(1H)‐one ( 1 ) with p‐aminoacetophenone ( 2 ) in pyridine. Reaction of p‐acetylcompound ( 3 ) with aromatic aldehydes yield the corresponding chalcones ( 4a‐c ). Condensation of latter chalcones with malononitrile afforded cyanopyridines ( 5a‐c ). Also, the reaction of chalcones ( 4a‐c ) with hydroxylamine hydrochloride furnished isoxazoles ( 6a‐c ). The reaction of bromo compound ( 1 ) with p‐aminobenzophenone yield ( 8 ) which was condenced with hydrazine hydrate to get the corresponding hydrazone derivatives ( 9 ). Some of the synthesized compounds have been screened for their antimicrobial activity against various strains of bacteria and fungi.     

Synthesis of Certain S-Triazole and s-Triazolo[3,4-B] 1,3,4-Thiadiazole Derivatives of Expected Pharmacological Activity

Reaction of the newly prepared 3-(2-thienyl)-4-amino-s-triazole-5-thione (I) with different alkyl kalides and aromatic aldehydes afforded the corresponding thioethers and arylidene derivatives (II and III), respectively. Attempt ring closure of (I) with acetic anhydride produced the unexpected triacetyl derivative (IV). The synthesis of certain 3-(2-thienyl)-6-substituted-s-triazolo[3,4-b] 1,3,4-thiadiazoles (V and VII) was described. IR, NMR and mass spectral analyses of the prepared compounds were discussed.     

Regio and stereoselective catalytic five-component cascades of diverse heterocyclic bisallenes: tri-directional exploration of biochemical space

We report protecting group free Pd(0) catalyzed cascade syntheses of molecular scaffolds built from heterocyclic bisallenes. These generate novel molecular architecture permitting tri-directional exploration of biochemical space.     

Studies on Thiazolopyridines. Part 4: Synthesis of Hitherto Unknown 1,4-Bis(thiazolopyridine)benzene Derivatives

2-Cyanomethyl-4-thiazolinone ( 1 ) was condensed with terephthalaldehyde ( 2 ) (2:1 molar ratio) and produced 1,4-bis(2-cyanomethyl-4,5-dihydro-5-methylidene-4-thiazolinone-5-yl) benzene ( 3 ). Treatment of compound ( 3 ) with benzylidenemalononitrile ( 4 ) (1:2 molar ratio) furnished the novel bisthiazolopyridines ( 6a-e ). Condensation of compound ( 1 ) with aromatic aldehyde yielded the benzylidene derivatives ( 7a-f ), which on treatment with compound ( 8 ) (2:1 molar ratio) afforded the novel bisthiazolopyridines ( 10a-f ). Structures of the synthesized compounds have been established by elemental analyses and spectral data.     

Stability-indicating methods for the determination of disopyramide phosphate

Four methods were developed for the determination of intact disopyramide phosphate in the presence of its degradation product. In the first and second methods, third-derivative spectrophotometry and first derivative of the ratio spectra were used. For the third-derivative spectrophotometric method, the peak amplitude was measured at 272 nm, while for the derivative ratio spectrophotometric method, disopyramide phosphate was determined by measuring the peak amplitude at 248 and 273 nm. Both methods were used for the determination of disopyramide phosphate in the concentration range 12.5-87.5 microg/mL, with corresponding mean recovery 100.8 +/- 0.7% for the first method and 99.9 +/- 0.7% and 99.6 +/- 0.7% for the second method at 248 and 273 nm, respectively. In the third method, an ion selective electrode (ISE) was fabricated using phosphotungstic acid as an anionic exchanger, PVC as the polymer matrix, and dibutylsebacate as a plasticizer. The ISE was used for the determination of disopyramide phosphate in pure powder form in the concentration range 10(-2)-10(-5) M. The slope was found to be 58.5 (mV/decade), and the average recovery was 99.9 +/- 1.6%. The fourth method depended on the quantitative densitometric determination of the drug in concentration range of 0.25-2.5 microg/spot using silica gel 60 F245 plates and ethyl acetate-chloroform-ammonium hydroxide (85 + 10 + 5, v/v/v) as the mobile phase, with corresponding mean accuracy of 100.3 +/- 1.1%. The 4 proposed methods were found to be specific for disopyramide phosphate in presence of up to 80% of its degradation product for the spectrophotometric methods, 90% of its degradation for the densitometric method, and 40% for the ISE method. The 4 proposed procedures were successfully applied for the determination of disopyramide phosphate in Norpace capsules. Statistical comparison between the results obtained by these methods and the official method of the drug was done, and no significant differences were found.